{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:44:30Z","timestamp":1776109470362,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00051\/2020"],"award-info":[{"award-number":["UIDB\/00051\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00051\/2020"],"award-info":[{"award-number":["UIDP\/00051\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0053\/2020"],"award-info":[{"award-number":["LA\/P\/0053\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04501\/2020"],"award-info":[{"award-number":["UIDB\/04501\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007628"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007628"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00051\/2020 (postdoc grant)"],"award-info":[{"award-number":["UIDP\/00051\/2020 (postdoc grant)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Aortic valve stenosis (AVS) is a growing healthcare burden. Aortic valve replacement (AVR) remains the only effective treatment to eliminate pressure overload and triggers myocardial reverse remodelling (RR), with regression of hypertrophy, fibrosis and diastolic function normalisation. However, many patients show an incomplete RR, being at higher risk of death. We aimed to uncover pathways and new therapeutic targets for incomplete RR through myocardial (phospho)proteomics. AVS patients were categorised based on left ventricle mass regression\u00a0(LVM): complete RR (\u2265\u200915%) or incomplete RR (\u2264\u20095%). 83 myocardial proteins were dysregulated through LC\u2013MS\/MS. Gene ontology enrichment analysis identified inflammation, complement and immune system activation as priming events of an incomplete RR and a better mitochondrial function underscoring complete RR. Kinetic metabolic modelling corroborated the lower ATP production capacity of incomplete RR patients. To uncover therapeutic targets, kinases were predicted from phosphoproteome data. Casein kinase 2 and DYRK1A were among the most dysregulated kinases in RR. DYRK1A was found to be inversely correlated with LVM regression (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u00a00.62). DYRK1A functional role (passive, maximal tension and Ca<jats:sup>2+<\/jats:sup> sensitivity) was evaluated in skinned cardiomyocytes from <jats:italic>Dyrk1a<\/jats:italic>\n            <jats:sup>+\/-<\/jats:sup> mice and from AVS patients upon incubation with this kinase. Cardiomyocytes from mutant mice showed increased myofilamentary stiffness in response to stretch. Also, the raised myofilamentary stiffness of cardiomyocytes isolated from incomplete RR was normalised upon incubation with DYRK1A. Better myocardial bioenergetics may underscore a complete LVM regression. In turn, complement and immune-inflammatory pathways activation prime an incomplete response to AVR. DYRK1A emerges as a surrogate target to treat myocardial stiffness-driven diastolic dysfunction.<\/jats:p>","DOI":"10.1007\/s00395-025-01125-w","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:34:25Z","timestamp":1751762065000},"page":"947-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Myocardial phosphoproteomics unveils a key role of DYRK1A in aortic valve replacement-induced reverse remodelling"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-2040","authenticated-orcid":false,"given":"F\u00e1bio","family":"Trindade","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-8962","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Almeida-Coelho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-6149","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Sousa-Mendes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-9962","authenticated-orcid":false,"given":"Francisca","family":"Saraiva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6035-0235","authenticated-orcid":false,"given":"Maria L.","family":"Arbon\u00e9s","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-3596","authenticated-orcid":false,"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-5805","authenticated-orcid":false,"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1937-3782","authenticated-orcid":false,"given":"In\u00eas","family":"Falc\u00e3o-Pires","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jacc.2021.11.060","volume":"79","author":"SX Li","year":"2022","unstructured":"Li SX, Patel NK, Flannery LD, Selberg A, Kandanelly RR, Morrison FJ, Kim J, Tanguturi VK, Crousillat DR, Shaqdan AW, Inglessis I, Shah PB, Passeri JJ, Kaneko T, Jassar AS, Langer NB, Turchin A, Elmariah S (2022) Trends in utilization of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol 79:864\u2013877. https:\/\/doi.org\/10.1016\/j.jacc.2021.11.060","journal-title":"J Am Coll Cardiol"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrcardio.2017.139","volume":"15","author":"GH Kim","year":"2017","unstructured":"Kim GH, Uriel N, Burkhoff D (2017) Reverse remodelling and myocardial recovery in heart failure. Nat Rev Cardiol 15:83\u201396. https:\/\/doi.org\/10.1038\/nrcardio.2017.139","journal-title":"Nat Rev Cardiol"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"H1402","DOI":"10.1152\/ajpheart.00696.2015","volume":"310","author":"PG Rodrigues","year":"2016","unstructured":"Rodrigues PG, Leite-Moreira AF, Falc\u00e3o-Pires I (2016) Myocardial reverse remodeling: how far can we rewind? Am J Physiol Heart Circ Physiol 310:H1402\u2013H1422. https:\/\/doi.org\/10.1152\/ajpheart.00696.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-8090-6-53","volume":"6","author":"RWW Biederman","year":"2011","unstructured":"Biederman RWW, Magovern JA, Grant SB, Williams RB, Yamrozik JA, Vido DA, Rathi VK, Rayarao G, Caruppannan K, Doyle M (2011) LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association. J Cardiothorac Surg 6:1\u20138. https:\/\/doi.org\/10.1186\/1749-8090-6-53","journal-title":"J Cardiothorac Surg"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jjcc.2015.09.017","volume":"68","author":"T Hatani","year":"2016","unstructured":"Hatani T, Kitai T, Murai R, Kim K, Ehara N, Kobori A, Kinoshita M, Kaji S, Tani T, Sasaki Y, Yamane T, Koyama T, Nasu M, Okada Y, Furukawa Y (2016) Associations of residual left ventricular and left atrial remodeling with clinical outcomes in patients after aortic valve replacement for severe aortic stenosis. J Cardiol 68:241\u2013247. https:\/\/doi.org\/10.1016\/j.jjcc.2015.09.017","journal-title":"J Cardiol"},{"key":"1125_CR6","first-page":"476","volume":"22","author":"HW Chang","year":"2013","unstructured":"Chang HW, Kim KH, Kim JS, Kim KH, Kim YJ (2013) Relationship between morphologic features of myocardial tissue and left ventricular function in patients with aortic valve disease and left ventricular hypertrophy. J Heart Valve Dis 22:476\u2013483","journal-title":"J Heart Valve Dis"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ejcts\/ezv240","volume":"49","author":"C Gavina","year":"2015","unstructured":"Gavina C, Falc\u00e3o-Pires I, Pinho P, Manso M-C, Gon\u00e7alves A, Rocha-Gon\u00e7alves F, Leite-Moreira A (2015) Relevance of residual left ventricular hypertrophy after surgery for isolated aortic stenosis. Eur J Cardiothorac Surg 49:952\u2013959. https:\/\/doi.org\/10.1093\/ejcts\/ezv240","journal-title":"Eur J Cardiothorac Surg"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijcard.2013.11.006","volume":"170","author":"C Gavina","year":"2014","unstructured":"Gavina C, Falc\u00e3o-Pires I, Rodrigues J, Marinho B, Gon\u00e7alves N, Lopes R, Amorim MJ, Almeida J, Pinho P, Gon\u00e7alves A, Rocha-Gon\u00e7alves F, Leite-Moreira A (2014) Load independent impairment of reverse remodeling after valve replacement in hypertensive aortic stenosis patients. Int J Cardiol 170:324\u2013330. https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.006","journal-title":"Int J Cardiol"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1540-8191.2005.200485.x","volume":"20","author":"N Hanayama","year":"2005","unstructured":"Hanayama N, Christakis GT, Mallidi HR, Rao V, Cohen G, Goldman BS, Fremes SE, Morgan CD, Joyner CD (2005) Determinants of incomplete left ventricular mass regression following aortic valve replacement for aortic stenosis. J Card Surg 20:307\u2013313. https:\/\/doi.org\/10.1111\/j.1540-8191.2005.200485.x","journal-title":"J Card Surg"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.amjcard.2012.07.041","volume":"110","author":"M Vaduganathan","year":"2012","unstructured":"Vaduganathan M, Lee R, Beckham AJ, Andrei A-C, Lapin B, Stone NJ, McGee EC, Malaisrie SC, Kansal P, Silverberg RA, Lloyd-Jones DM, McCarthy PM (2012) Relation of body mass index to late survival after valvular heart surgery. Am J Cardiol 110:1667\u20131678. https:\/\/doi.org\/10.1016\/j.amjcard.2012.07.041","journal-title":"Am J Cardiol"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/cvr\/cvp344","volume":"85","author":"H Bugger","year":"2009","unstructured":"Bugger H, Schwarzer M, Chen D, Schrepper A, Amorim PA, Schoepe M, Nguyen TD, Mohr FW, Khalimonchuk O, Weimer BC, Doenst T (2009) Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res 85:376\u2013384. https:\/\/doi.org\/10.1093\/cvr\/cvp344","journal-title":"Cardiovasc Res"},{"key":"1125_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185915","volume":"12","author":"J R\u00fcdebusch","year":"2017","unstructured":"R\u00fcdebusch J, Benkner A, Poesch A, D\u00f6rr M, V\u00f6lker U, Grube K, Hammer E, Felix SB (2017) Dynamic adaptation of myocardial proteome during heart failure development. PLoS ONE 12:e0185915. https:\/\/doi.org\/10.1371\/journal.pone.0185915","journal-title":"PLoS ONE"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1074\/mcp.M113.027649","volume":"12","author":"Y-W Chang","year":"2013","unstructured":"Chang Y-W, Chang Y-T, Wang Q, Lin JJ-C, Chen Y-J, Chen C-C (2013) Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophy. Mol Cell Proteomics 12:3094\u20133107. https:\/\/doi.org\/10.1074\/mcp.M113.027649","journal-title":"Mol Cell Proteomics"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1021\/pr0503275","volume":"5","author":"J Gallego-Delgado","year":"2006","unstructured":"Gallego-Delgado J, Lazaro A, Osende JI, Barderas MG, Duran MC, Vivanco F, Egido J (2006) Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. J Proteome Res 5:404\u2013413. https:\/\/doi.org\/10.1021\/pr0503275","journal-title":"J Proteome Res"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1681\/ASN.2006080937","volume":"17","author":"J Gallego-Delgado","year":"2006","unstructured":"Gallego-Delgado J, Lazaro A, Osende JI, Esteban V, Barderas MG, Gomez-Guerrero C, Vega R, Vivanco F, Egido J (2006) Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. J Am Soc Nephrol 17:S159\u2013S164. https:\/\/doi.org\/10.1681\/ASN.2006080937","journal-title":"J Am Soc Nephrol"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13105-010-0039-1","volume":"66","author":"L Liu","year":"2010","unstructured":"Liu L, Wang W, Meng X, Gao J, Wu H, Wang P, Wu W, Wang L, Ma L, Zhang W (2010) Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan\u2014a proteomic analysis. J Physiol Biochem 66:329\u2013338. https:\/\/doi.org\/10.1007\/s13105-010-0039-1","journal-title":"J Physiol Biochem"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","volume":"6","author":"DF Dai","year":"2013","unstructured":"Dai DF, Hsieh EJ, Chen T, Menendez LG, Basisty NB, Tsai L, Beyer RP, Crispin DA, Shulman NJ, Szeto HH, Tian R (2013) Global proteomics and pathway analysis of pressure-overload\u2013induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail 6:1067\u20131076. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000406","journal-title":"Circ Heart Fail"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.healun.2010.11.011","volume":"30","author":"RA de Weger","year":"2011","unstructured":"de Weger RA, Schipper MEI, Koning ES, van der Weide P, van Oosterhout MFM, Quadir R, Steenbergen-Nakken H, Lahpor JR, de Jonge N, Bovenschen N (2011) Proteomic profiling of the human failing heart after left ventricular assist device support. J Heart Lung Transplant 30:497\u2013506. https:\/\/doi.org\/10.1016\/j.healun.2010.11.011","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"1125_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ejcts\/ezx023","volume":"51","author":"JH Shahinian","year":"2017","unstructured":"Shahinian JH, Mayer B, Tholen S, Brehm K, Biniossek ML, F\u00fcllgraf H, Kiefer S, Heizmann U, Heilmann C, R\u00fcter F, Grapow M, Reuthebuch OT, Eckstein F, Beyersdorf F, Schilling O, Siepe M (2017) Proteomics highlights decrease of matricellular proteins in left ventricular assist device therapy. Eur J Cardiothorac Surg 51(6):1063\u20131071. https:\/\/doi.org\/10.1093\/ejcts\/ezx023","journal-title":"Eur J Cardiothorac Surg"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","volume":"22","author":"H Baumgartner","year":"2009","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Qui\u00f1ones M (2009) Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice. J Am Soc Echocardiogr 22:1\u201323. https:\/\/doi.org\/10.1016\/j.echo.2008.11.029","journal-title":"J Am Soc Echocardiogr"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt J-U (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013271. https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.echo.2023.10.004","volume":"37","author":"WA Zoghbi","year":"2024","unstructured":"Zoghbi WA, Jone P-N, Chamsi-Pasha MA, Chen T, Collins KA, Desai MY, Grayburn P, Groves DW, Hahn RT, Little SH, Kruse E, Sanborn D, Shah SB, Sugeng L, Swaminathan M, Thaden J, Thavendiranathan P, Tsang W, Weir-McCall JR, Gill E (2024) Guidelines for the evaluation of prosthetic valve function with cardiovascular imaging: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 37:2\u201363. https:\/\/doi.org\/10.1016\/j.echo.2023.10.004","journal-title":"J Am Soc Echocardiogr"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0735-1097(00)00859-7","volume":"36","author":"P Pibarot","year":"2000","unstructured":"Pibarot P, Dumesnil JG (2000) Hemodynamic and clinical impact of prosthesis\u2013patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 36:1131\u20131141. https:\/\/doi.org\/10.1016\/S0735-1097(00)00859-7","journal-title":"J Am Coll Cardiol"},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13:2513\u20132526. https:\/\/doi.org\/10.1074\/mcp.M113.031591","journal-title":"Mol Cell Proteomics"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y (2012) Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman W-H, Pag\u00e8s F, Trajanoski Z, Galon J (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25:1091\u20131093. https:\/\/doi.org\/10.1093\/bioinformatics\/btp101","journal-title":"Bioinformatics"},{"key":"1125_CR27","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1161\/CIRCULATIONAHA.121.055646","volume":"144","author":"N Berndt","year":"2021","unstructured":"Berndt N, Eckstein J, Wallach I, Nordmeyer S, Kelm M, Kirchner M, Goubergrits L, Schafstedde M, Hennemuth A, Kraus M, Grune T, Mertins P, Kuehne T, Holzh\u00fctter H-G (2021) CARDIOKIN1: computational assessment of myocardial metabolic capability in healthy controls and patients with valve diseases. Circulation 144:1926\u20131939. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055646","journal-title":"Circulation"},{"key":"1125_CR28","doi-asserted-by":"publisher","first-page":"W184","DOI":"10.1093\/nar\/gki393","volume":"33","author":"Y Xue","year":"2005","unstructured":"Xue Y, Zhou F, Zhu M, Ahmed K, Chen G, Yao X (2005) GPS: a comprehensive www server for phosphorylation sites prediction. Nucleic Acids Res 33:W184\u2013W187. https:\/\/doi.org\/10.1093\/nar\/gki393","journal-title":"Nucleic Acids Res"},{"key":"1125_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680\u2013685. https:\/\/doi.org\/10.1038\/227680a0","journal-title":"Nature"},{"key":"1125_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ab.2016.03.023","volume":"504","author":"MAS Fortes","year":"2016","unstructured":"Fortes MAS, Marzuca-Nassr GN, Vitzel KF, da Justa Pinheiro CH, Newsholme P, Curi R (2016) Housekeeping proteins: how useful are they in skeletal muscle diabetes studies and muscle hypertrophy models? Anal Biochem 504:38\u201340. https:\/\/doi.org\/10.1016\/j.ab.2016.03.023","journal-title":"Anal Biochem"},{"key":"1125_CR31","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","volume":"22","author":"V Fotaki","year":"2002","unstructured":"Fotaki V, Dierssen M, Alc\u00e1ntara S, Mart\u00ednez S, Mart\u00ed E, Casas C, Visa J, Soriano E, Estivill X, Arbon\u00e9s ML (2002) Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 22:6636\u20136647. https:\/\/doi.org\/10.1128\/MCB.22.18.6636-6647.2002","journal-title":"Mol Cell Biol"},{"key":"1125_CR32","doi-asserted-by":"publisher","DOI":"10.3791\/60427","author":"P Gon\u00e7alves-Rodrigues","year":"2020","unstructured":"Gon\u00e7alves-Rodrigues P, Almeida-Coelho J, Gon\u00e7alves A, Amorim F, Leite-Moreira AF, Stienen GJM, Falc\u00e3o-Pires I (2020) In vitro assessment of cardiac function using skinned cardiomyocytes. J Vis Exp. https:\/\/doi.org\/10.3791\/60427","journal-title":"J Vis Exp"},{"key":"1125_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.molimm.2016.06.013","volume":"76","author":"H Li","year":"2016","unstructured":"Li H, Zhang S, Li F, Qin L (2016) NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation. Mol Immunol 76:90\u201397. https:\/\/doi.org\/10.1016\/j.molimm.2016.06.013","journal-title":"Mol Immunol"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10238-018-0491-8","volume":"18","author":"E \u0141ukawska","year":"2018","unstructured":"\u0141ukawska E, Polcyn-Adamczak M, Niemir ZI (2018) The role of the alternative pathway of complement activation in glomerular diseases. Clin Exp Med 18:297\u2013318. https:\/\/doi.org\/10.1007\/s10238-018-0491-8","journal-title":"Clin Exp Med"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1096\/fj.10-165837","volume":"25","author":"S Aranda","year":"2010","unstructured":"Aranda S, Laguna A, de la Luna S (2010) DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J 25:449\u2013462. https:\/\/doi.org\/10.1096\/fj.10-165837","journal-title":"FASEB J"},{"key":"1125_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42445-x","volume":"9","author":"J Roewenstrunk","year":"2019","unstructured":"Roewenstrunk J, Di Vona C, Chen J, Borras E, Dong C, Arat\u00f3 K, Sabid\u00f3 E, Huen MSY, de la Luna S (2019) A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response. Sci Rep 9:6014. https:\/\/doi.org\/10.1038\/s41598-019-42445-x","journal-title":"Sci Rep"},{"key":"1125_CR37","doi-asserted-by":"publisher","first-page":"17320","DOI":"10.1074\/jbc.M109.006759","volume":"284","author":"C Kuhn","year":"2009","unstructured":"Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, Frey N (2009) DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy. J Biol Chem 284:17320\u201317327. https:\/\/doi.org\/10.1074\/jbc.M109.006759","journal-title":"J Biol Chem"},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtcvs.2012.12.016","volume":"147","author":"JM Beach","year":"2014","unstructured":"Beach JM, Mihaljevic T, Rajeswaran J, Marwick T, Edwards ST, Nowicki ER, Thomas J, Svensson LG, Griffin B, Gillinov AM, Blackstone EH (2014) Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 147:362\u2013369. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.12.016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1125_CR39","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"H Stefan","year":"2003","unstructured":"Stefan H, Eyal A, Sawa K, Markus S, Albrecht E, Victoria P, Be P, Wolf-Peter K, Jutta S (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Circulation 107:984\u2013991. https:\/\/doi.org\/10.1161\/01.CIR.0000051865.66123.B7","journal-title":"Circulation"},{"key":"1125_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/ajh\/hpt274","volume":"27","author":"C Zhang","year":"2014","unstructured":"Zhang C, Li Y, Wang C, Wu Y, Du J (2014) Antagonist of C5aR prevents cardiac remodeling in Angiotensin II\u2013induced hypertension. Am J Hypertens 27:857\u2013864. https:\/\/doi.org\/10.1093\/ajh\/hpt274","journal-title":"Am J Hypertens"},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/nejmra1106180","volume":"368","author":"M Willis","year":"2013","unstructured":"Willis M, Patterson C (2013) Proteotoxicity and cardiac dysfunction\u2014Alzheimer\u2019s disease of the heart? N Engl J Med 368:455\u2013464. https:\/\/doi.org\/10.1056\/nejmra1106180","journal-title":"N Engl J Med"},{"key":"1125_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237000","volume":"15","author":"F Trindade","year":"2020","unstructured":"Trindade F, Saraiva F, Keane S, Leite-Moreira A, Vitorino R, Tajsharghi H, Falc\u00e3o-Pires I (2020) Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy. PLoS ONE 15:e0237000. https:\/\/doi.org\/10.1371\/journal.pone.0237000","journal-title":"PLoS ONE"},{"key":"1125_CR43","doi-asserted-by":"publisher","first-page":"41490","DOI":"10.1038\/srep41490","volume":"7","author":"K Dadson","year":"2017","unstructured":"Dadson K, Hauck L, Hao Z, Grothe D, Rao V, Mak TW, Billia F (2017) The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1\u03b1 and Pink1. Sci Rep 7:41490. https:\/\/doi.org\/10.1038\/srep41490","journal-title":"Sci Rep"},{"key":"1125_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006170","author":"D Miranda-Silva","year":"2020","unstructured":"Miranda-Silva D, Rodrigues PG, Alves E, Rizo D, Fonseca ACRG, Lima T, Baganha F, Concei\u00e7\u00e3o G, Sousa C, Gon\u00e7alves A, Miranda I, Vasques-N\u00f3voa F, Magalh\u00e3es J, Leite-Moreira A, Falc\u00e3o-Pires I (2020) Mitochondrial reversible changes determine diastolic function adaptations during myocardial (reverse) remodeling. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006170","journal-title":"Circ Heart Fail"},{"key":"1125_CR45","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.yjmcc.2005.02.013","volume":"38","author":"T Santaluc\u00eda","year":"2005","unstructured":"Santaluc\u00eda T, S\u00e1nchez-Feutrie M, Felkin LE, Bhavsar PK, Barton PJR, Zorzano A, Yacoub MH, Brand NJ (2005) Phenylephrine requires the TATA box to activate transcription of GLUT1 in neonatal rat cardiac myocytes. J Mol Cell Cardiol 38:677\u2013684. https:\/\/doi.org\/10.1016\/j.yjmcc.2005.02.013","journal-title":"J Mol Cell Cardiol"},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1038\/s41467-020-18165-6","volume":"11","author":"ED Luczak","year":"2020","unstructured":"Luczak ED, Wu Y, Granger JM, Joiner MA, Wilson NR, Gupta A, Umapathi P, Murphy KR, Reyes Gaido OE, Sabet A, Corradini E, Tseng W-W, Wang Y, Heck AJR, Wei A-C, Weiss RG, Anderson ME (2020) Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy. Nat Commun 11:4416. https:\/\/doi.org\/10.1038\/s41467-020-18165-6","journal-title":"Nat Commun"},{"key":"1125_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11748-009-0505-2","volume":"58","author":"A Tateishi","year":"2010","unstructured":"Tateishi A, Matsushita M, Asai T, Masuda Z, Kuriyama M, Kanki K, Ishino K, Kawada M, Sano S, Matsui H (2010) Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload. Gen Thorac Cardiovasc Surg 58:265\u2013270. https:\/\/doi.org\/10.1007\/s11748-009-0505-2","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"1125_CR48","doi-asserted-by":"publisher","first-page":"33181","DOI":"10.1074\/jbc.M705133200","volume":"282","author":"P Zhai","year":"2007","unstructured":"Zhai P, Gao S, Holle E, Yu X, Yatani A, Wagner T, Sadoshima J (2007) Glycogen synthase kinase-3\u03b1 reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases. J Biol Chem 282:33181\u201333191. https:\/\/doi.org\/10.1074\/jbc.M705133200","journal-title":"J Biol Chem"},{"key":"1125_CR49","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/cvr\/cvr023","volume":"90","author":"C Grebe","year":"2011","unstructured":"Grebe C, Klingebiel T-M, Grau SP, Toischer K, Didi\u00e9 M, Jacobshagen C, Dullin C, Hasenfuss G, Seidler T (2011) Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo. Cardiovasc Res 90:521\u2013528. https:\/\/doi.org\/10.1093\/cvr\/cvr023","journal-title":"Cardiovasc Res"},{"key":"1125_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/cvr\/cvw074","volume":"110","author":"S Hille","year":"2016","unstructured":"Hille S, Dierck F, K\u00fchl C, Sosna J, Adam-Klages S, Adam D, L\u00fcllmann-Rauch R, Frey N, Kuhn C (2016) Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb\/E2f-signalling. Cardiovasc Res 110:381\u2013394. https:\/\/doi.org\/10.1093\/cvr\/cvw074","journal-title":"Cardiovasc Res"},{"key":"1125_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add6883","author":"E Lana-Elola","year":"2024","unstructured":"Lana-Elola E, Aoidi R, Llorian M, Gibbins D, Buechsenschuetz C, Bussi C, Flynn H, Gilmore T, Watson-Scales S, Haugsten Hansen M, Hayward D, Song O-R, Brault V, Herault Y, Deau E, Meijer L, Snijders AP, Gutierrez MG, Fisher EMC, Tybulewicz VLJ (2024) Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.add6883","journal-title":"Sci Transl Med"},{"key":"1125_CR52","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/ncb2126","volume":"12","author":"PA da Costa Martins","year":"2010","unstructured":"da Costa Martins PA, Salic K, Gladka MM, Armand A-S, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ (2010) Microrna-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin\/NFAT signalling. Nat Cell Biol 12:1220\u20131227. https:\/\/doi.org\/10.1038\/ncb2126","journal-title":"Nat Cell Biol"},{"key":"1125_CR53","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1113\/JP270354","volume":"593","author":"V Sequeira","year":"2015","unstructured":"Sequeira V, Najafi A, McConnell M, Fowler ED, Bollen IAE, W\u00fcst RCI, dos Remedios C, Helmes M, White E, Stienen GJM, Tardiff J, Kuster DWD, van der Velden J (2015) Synergistic role of ADP and Ca2+ in diastolic myocardial stiffness. J Physiol 593:3899\u20133916. https:\/\/doi.org\/10.1113\/JP270354","journal-title":"J Physiol"},{"key":"1125_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0008-6363(98)00337-X","volume":"42","author":"J van der Velden","year":"1999","unstructured":"van der Velden J, Klein LJ, van der Bijl M, Huybregts MAJM, Stooker W, Witkop J, Eijsman L, Visser CA, Visser FC, Stienen GJM (1999) Isometric tension development and its calcium sensitivity in skinned myocyte-sized preparations from different regions of the human heart. Cardiovasc Res 42:706\u2013719. https:\/\/doi.org\/10.1016\/S0008-6363(98)00337-X","journal-title":"Cardiovasc Res"},{"key":"1125_CR55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.gene.2015.10.052","volume":"576","author":"J-J Sheng","year":"2016","unstructured":"Sheng J-J, Jin J-P (2016) TNNI1, TNNI2 and TNNI3: evolution, regulation, and protein structure\u2013function relationships. Gene 576:385\u2013394. https:\/\/doi.org\/10.1016\/j.gene.2015.10.052","journal-title":"Gene"},{"key":"1125_CR56","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1134\/S0006297913130063","volume":"78","author":"IA Katrukha","year":"2013","unstructured":"Katrukha IA (2013) Human cardiac troponin complex. Struct Funct Biochem 78:1447\u20131465. https:\/\/doi.org\/10.1134\/S0006297913130063","journal-title":"Struct Funct Biochem"},{"key":"1125_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cardfail.2015.05.015","volume":"21","author":"J He","year":"2015","unstructured":"He J, Yao J, Sheng H, Zhu J (2015) Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A\u2013alternative splicing factor\u2013calcium\/calmodulin-dependent protein kinase II\u03b4 signaling pathway in myocardial infarction-induced heart failure of rats. J Card Fail 21:751\u2013760. https:\/\/doi.org\/10.1016\/j.cardfail.2015.05.015","journal-title":"J Card Fail"},{"key":"1125_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","volume":"116","author":"L Hind","year":"2015","unstructured":"Hind L, Firdos A, James W, Thomas F (2015) The GSK-3 family as therapeutic target for myocardial diseases. Circ Res 116:138\u2013149. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303613","journal-title":"Circ Res"},{"key":"1125_CR59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yjmcc.2013.04.012","volume":"60","author":"V Kooij","year":"2013","unstructured":"Kooij V, Holewinski RJ, Murphy AM, Van Eyk JE (2013) Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts. J Mol Cell Cardiol 60:116\u2013120. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.04.012","journal-title":"J Mol Cell Cardiol"},{"key":"1125_CR60","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","volume":"2","author":"BR Lindman","year":"2016","unstructured":"Lindman BR, Clavel M-A, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P (2016) Calcific aortic stenosis. Nat Rev Dis Primers 2:16006. https:\/\/doi.org\/10.1038\/nrdp.2016.6","journal-title":"Nat Rev Dis Primers"},{"key":"1125_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591815","author":"H Zhang","year":"2020","unstructured":"Zhang H, Xiao Y, Nederlof R, Bakker D, Zhang P, Girardin SE, Hollmann MW, Weber NC, Houten SM, van Weeghel M, Kibbey RG, Zuurbier CJ (2020) NLRX1 deletion increases ischemia-reperfusion damage and activates glucose metabolism in mouse heart. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.591815","journal-title":"Front Immunol"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-025-01125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-025-01125-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-025-01125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:04:47Z","timestamp":1760367887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-025-01125-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s00395-025-01125-w","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}